Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors

Bibliographic Details
Title: Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors
Authors: Adeshina I. Odugbemi, Clement Nyirenda, Alan Christoffels, Samuel A. Egieyeh
Source: Computational and Structural Biotechnology Journal, Vol 23, Iss , Pp 2964-2977 (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Biotechnology
Subject Terms: QSAR, Molecular descriptors, Machine learning, Deep learning, Diabetes, α-glucosidase, Biotechnology, TP248.13-248.65
More Details: Artificial Intelligence is transforming drug discovery, particularly in the hit identification phase of therapeutic compounds. One tool that has been instrumental in this transformation is Quantitative Structure-Activity Relationship (QSAR) analysis. This computer-aided drug design tool uses machine learning to predict the biological activity of new compounds based on the numerical representation of chemical structures against various biological targets. With diabetes mellitus becoming a significant health challenge in recent times, there is intense research interest in modulating antidiabetic drug targets. α-Glucosidase is an antidiabetic target that has gained attention due to its ability to suppress postprandial hyperglycaemia, a key contributor to diabetic complications. This review explored a detailed approach to developing QSAR models, focusing on strategies for generating input variables (molecular descriptors) and computational approaches ranging from classical machine learning algorithms to modern deep learning algorithms. We also highlighted studies that have used these approaches to develop predictive models for α-glucosidase inhibitors to modulate this critical antidiabetic drug target.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2001-0370
Relation: http://www.sciencedirect.com/science/article/pii/S200103702400237X; https://doaj.org/toc/2001-0370
DOI: 10.1016/j.csbj.2024.07.003
Access URL: https://doaj.org/article/13bc196e36e14e1a8560a9f8872d564e
Accession Number: edsdoj.13bc196e36e14e1a8560a9f8872d564e
Database: Directory of Open Access Journals
More Details
ISSN:20010370
DOI:10.1016/j.csbj.2024.07.003
Published in:Computational and Structural Biotechnology Journal
Language:English